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Abstract
Background: Thioredoxin interacting protein (Txnip) is a multifunctional protein involved in regulation of cell cycle events
and cellular metabolism. The expression of Txnip is known to be induced by glucose, adenosine-containing molecules, and
other physiological cues; however, the underlying regulatory mechanisms remain elusive.
Methodology/Principal Findings: In this study, using promoter reporter, electrophoresis mobility shift (EMSA), and
chromatin immuno-precipitation (ChIP) assays, we have identified an additional carbohydrate response element (ChoRE) on
the promoter of Txnip gene, which functions cooperatively with the earlier identified ChoRE to mediate optimal Txnip
expression. However, these two ChoREs are not sufficient to mediate the induction of Txnip expression by glucose or
adenosine-containing molecules; and two CCAAT boxes, both of which can recruit nuclear factor Y (NF-Y) to the Txnip
promoter, are also required for the induction. Accordingly, we have found that the function of ChoREs and associated
factors is contingent on tandem CCAAT boxes, in that occupancy of the Txnip promoter by NF-Y is a prerequisite for
efficacious recruitment of Mondo/MLX to ChoREs under glucose stimulation.
Conclusions/Significance: Our findings suggest a synergy between the tandem CCAAT and ChoRE motifs and associated
NF-Y and Mondo/MLX transcription factors in enhancing transcription from the Txnip promoter. This piece of information
will be helpful for future dissection of molecular mechanisms governing the transcriptional regulation of Txnip, a glucose
responsive gene.
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Introduction
Thioredoxin interacting protein (Txnip, also known as VDUP1
and TBP-2) is involved in many cellular and physiological
processes [1–3]. First, Txnip can regulate cellular redox state by
inhibiting the activity of thioredoxin [2,4–6]. Second, Txnip is a
candidate of tumor suppressors, as it can suppress cell cycle
progression [7–13]. Third, suggesting a role in cell differentiation,
the development of natural killer cells in Txnip deficient mice is
disrupted [14]. Fourth, Txnip can promote apoptosis by
modulating the function of the apoptosis signal-regulating kinase
1 (ASK1) [5,15]. Finally, a wealth of accumulated information
suggests an intimate involvement of Txnip in regulating glucose
and lipid metabolism [16–29].
A number of physiological cues can dictate the efficacy of Txnip
expression, which is inhibited by insulin [20], stimulated by
glucocorticoid [30,31], vitamin D [3], peroxisome proliferator-
activated receptor (PPAR) agonist [32–34], transforming growth
factor beta (TGF-b) [11], suberoylanilide hydroxamic acid
(SAHA, an inhibitor of histone deacetylase [HDAC]) [13,35],
adenosine-containing molecules and certain stress signals [36,37].
Most interestingly, the expression level of Txnip is tightly
correlated with the extracellular glucose levels [22,25,27,28,37],
and this glucose-induced Txnip expression negatively feeds back to
the cellular glucose uptake system [17,20]. Thus, Txnip may play
an important role in glucose homeostasis.
While majority of Txnip-related research focuses on the Txnip
function, the underlying mechanisms that govern Txnip gene
transcription are largely unknown despite the identification of a lot
of modulators for Txnip expression. For the glucose- or adenosine-
containing molecules- induced Txnip expression, MondoA and
Max-like protein X (MLX) function through carbohydrate
response element (ChoRE) and are crucial for transmitting signals
into the nucleus to activate the Txnip promoter [16,37]; however,
a detailed description of this signaling pathway and the regulatory
mechanisms at the promoter level remains elusive.
Here, we show a dissection of the Txnip promoter in a detailed
manner, which reveals a requirement for tandem ChoRE and
CCAAT motifs that in conjunction with associated factors support
optimal Txnip expression outputs in response to glucose or
adenosine-containing molecules. We propose a model in which
ChoRE- and CCAAT-associated factors, upon receiving signals
from diverse physiological cues, induce dynamic changes at Txnip
promoter in a synergistic manner and enhance Txnip expression.
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Txnip Promoter Regions Critical for Expression Induction
by NAD
+ or Glucose
Previously, it has been shown that a 269 bp Txnip promoter
fragment was sufficient, and in which the earlier identified ChoRE
site (at ,80 bp upstream of the transcriptional start site) was
essential, to support the Txnip expression induction by glucose or
adenosine-containing molecules [22,37]; however, the minimal
promoter that remains inducible by these molecules was not yet
defined. To this end, we performed a more detailed promoter
analysis. Txnip promoters with different lengths were generated
and fused to a luciferase reporter gene. When ectopically
introduced into HeLa cells, reporters with 142 bp or longer
promoter sequences exhibited ,4-fold, and a reporter with 111 bp
sequences showed ,2-fold, stimulation by NAD
+; however,
reporters with shorter sequences were not responsive to NAD
+
(Figures 1A and S1A). In sharp contrast, in U2OS cells, NAD
+
showed marginal effect on all ectopic reporters with less than
169 bp Txnip promoter sequences, and reporters with longer
sequences exhibited similar stimulation by NAD
+ as in HeLa cells
(Figures 1A and S1B). Given that the previously identified ChoRE
locates at ,80 bp upstream of the transcriptional start site, this
ChoRE is apparently not sufficient to support optimal induction of
Txnip expression by NAD
+.
We have also tested the effect of glucose on these Txnip
promoters. In L6 cells, ectopic promoters with 111 bp or less
sequences were not responsive to glucose; however, promoters
with 142 bp or longer sequences showed 4-8-fold stimulation by
glucose (Figures 1B and S1C). This suggests that the earlier
defined ChoRE alone cannot support optimal induction of Txnip
expression by glucose, and that some nucleotide sequences
upstream of this ChoRE is also critical for the responsiveness of
Txnip promoter to glucose.
To identify minimal promoter sequences required for the
induction of Txnip expression by adenosine-containing molecules,
various Txnip promoter fragments were fused to a TATA-only
core promoter-luciferase reporter gene (Figure 2A), and their
responses to NAD
+ were tested in U2OS cells. As shown
(Figure 2B), a promoter fragment (184–63 bp upstream of the
transcription start site) was sufficient to support the induction by
NAD
+, while a fragment (269–95) lacking an earlier defined
ChoRE or fragments (145–63 or d170) lacking sequences
surrounding the 2170 positions did not respond to NAD
+.W e
conclude that both the earlier defined ChoRE and nucleotide
sequences near the 2170 positions are critical for the induction of
Txnip expression by adenosine-containing molecules.
The responses of the Txnip expression to extracellular glucose
or adenosine-containing molecules are general phenomena that
have been observed in diverse mammalian cell lines from
different tissue origins; however, the fold of response to the
adenosine-containing molecules was most prominent in U2OS
cells, and the fold of response to glucose was most dramatic in L6
cells ([37] and data not shown). Thus, in most experiments, we
respectively used U2OS or L6 cell lines to test the Txnip
promoter activities in cells treated by adenosine-containing
molecules or glucose.
Tandem ChoREs on Txnip Promoters
We examined the Txnip promoter sequences (184–63 bp) and
found that, apart from the known ChoRE (CACGAGggcagCAC-
GAG; ,80 bp upstream of the transcription start site), the
nucleotide sequences around the 2170 region (CACACCgtgtc-
CACGCG; Figure 2C) mimicked a degenerate ChoRE, which is
defined as two E-boxes (CACGTG) separated by 5 nucleotides
[38]. Thus, an additional candidate ChoRE sequence on the
Txnip gene promoter was identified; for convenience, we dubbed
the previously identified ChoRE (,80 bp) as ChoRE-a and the
newly identified ChoRE (,170 bp) as ChoRE-b (Figure 2C).
Bioinformatics efforts allowed us to conclude that Txnip is
vertebrate-specific, and obtain genomic sequences of Txnip
promoters of diverse species from fishes to humans. We aligned
the Txnip promoter sequences and found that the two ChoRE
sequences, a CCAAT box, an inverted CCAAT box and a
forkhead box O (FOXO) binding site were all well conserved
among these species (Figure S2). We built a phylogenic tree based
on the similarity of sequences covering the two ChoREs, and the
tree fitted well with the evolutionary tree (fishRamphibianR
mammals; Figure S3). In fish (fugu, tetraodon, zebrafish and
medaka) Txnip promoters, the nucleotide sequences at the
ChoRE-a position actually deviate from a canonical ChoRE; on
the contrary, the fish ChoRE-b better mimics a canonical ChoRE
sequence than does human ChoRE-b (Figure S4). The sequences
of both the ChoRE sites on the frog Txnip promoter are
moderately degenerate thus lying in between the fishes and
mammals (Figures S2, S3, and S4).
Figure 1. The induction of truncated Txnip promoters by NAD
+
(A) or Glucose (B). Numbers under bars indicate length (upstream of
the transcription start site) of corresponding Txnip promoters. Asterisk
and diamond: significant different from pGL3 vectors, n=2.
doi:10.1371/journal.pone.0008397.g001
Txnip Gene Transcription
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Vitro
It was shown previously that the earlier defined ChoRE (i.e.,
ChoRE-a) recruited a protein complex of MondoA and MLX;
thus we sought to know whether the newly identified ChoRE
(ChoRE-b) could also function as an anchor for MondoA and
MLX. To this end, we performed electrophoresis mobility shift
assays (EMSAs; Figure 3) using
33P-end-labeled probes and whole
cell extract prepared from cells over-expressing ectopic HA-
MondoA and Myc-MLX. Similar to a probe containing the
ChoRE-a and CCAAT box (Figure 3A, lane 2), a probe
containing the ChoRE-b and inverted CCAAT box formed
multiple DNA-protein complexes (Figure 3A, lane 10); the
formation of these complexes were significantly reduced by molar
excess of unlabeled probes (WT; lanes 3 and 11). When molar
excess of unlabeled probes of mutated ChoRE sites were used, two
bands were preserved (lanes 4 and 12); the higher band (star)
contained MondoA and MLX (see below), and the lower one
might be due to an unknown ChoRE- or E-box-binding protein(s).
The two bands were competed by shorter cold probes containing
ChoREs but lacking the CCAAT boxes (sCho-a or sCho-b; lanes 7
and 15) but not by similar probes containing mutated ChoREs
(msCho-a or msCho-b; lanes 8 and 16). When cold probes with
mutations at the CCAAT box (mCAT) or the inverted CCAAT
box (miCAT) were used in competition assays, two bands were
preserved (arrows, lanes 5 and 13); these two bands were
significantly competed by a short cold probe containing ATTGG
sequences (sNFY, lanes 6 and 14). These results suggest that both
labeled probes (CAT/ChoRE-a and iCAT/ChoRE-b) can at least
form three major DNA-protein complexes, one (star) is formed
between ChoRE and the MondoA/MLX complex, and the other
two (arrows) are formed between CCAAT boxes (CCAAT or
inverted CCAAT) and their associated factors.
To obtain identities of the protein(s) present in these complexes,
we included antibodies in EMSAs (Figure 3B). The band
corresponding to ChoRE (single star) was abolished by anti-HA
antibodies (lanes 4 and 12), and super-shifted by anti-Myc (lanes 5
and 13; double stars) or anti-MLX (lanes 8 and 16; triple stars)
antibodies. The bands corresponding to CCAAT or inverted
CCAAT boxes (arrows) were super-shifted by anti-NF-YA
antibodies (lanes 6 and 14; double head arrow). Naive mouse or
rabbit IgG (mIgG or rIgG) as a control did not change the EMSA
patterns. We conclude that HA-MondoA and Myc-MLX are able
to interact with both ChoRE-a and ChoRE-b, and that nuclear
factor Y (NF-Y) complex can bind to both the CCAAT and
inverted CCAAT boxes, on the Txnip promoter.
Both ChoREs Are Required for Optimal Txnip Promoter
Activity
To confirm whether both ChoREs are involved in the induction
of Txnip expression by glucose or adenosine-containing molecules,
we have generated reporter genes driven by Txnip promoters
containing mutations at ChoRE-a [37], ChoRE-b or both
(dmChoRE, refer to Figure 2C), and tested their response to
adenosine-containing molecules or glucose. As shown (Figure 4A
and 4B), when either ChoRE or both ChoREs were mutated, the
reporter genes were no longer induced by NAD
+. For the glucose
response test, the activities of promoters with mutated ChoRE-a or
with double mutations at both ChoREs were not stimulated by
glucose; and as compared with the wild type promoter, the
response of the ChoRE-b mutant promoter was significantly
reduced (Figure 4C and 4D). These results suggest that both
ChoREs are required for optimal induction of Txnip expression
by adenosine-containing molecules or glucose.
Given that the mChoRE-a mutant Txnip promoter possesses a
more dramatically reduced response to glucose than the
mChoRE-b mutant counterpart, ChoRE-a could play a major
role in glucose sensing (also see discussion). On the other hand,
responses of these two promoters to NAD
+ were similar in U2OS
cells. This may be due to a unique feature of the cell line used in
Figure 2. The minimal Txnip promoter sequence required for mediating the stimulatory effect of NAD
+. (A) Txnip promoter segments
with or without deletions were fused to a TATA box driven luciferase reporter, these hybrid promoters were used in (B). (B) the response of Txnip
promoters to NAD
+ treatment in U2OS cells; asterisk: significant different from TATA only promoter, n=2. (C) Txnip promoter sequences critical for
mediating the stimulatory effect of NAD
+, and potential cis-regulatory elements in this region, numbers indicate the distance to the transcription start
site. Modified nucleotides introduced into mutant Txnip promoters are indicated by lower case letters.
doi:10.1371/journal.pone.0008397.g002
Txnip Gene Transcription
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+ response, the reduced
response of the mChoRE-a mutant Txnip promoter was to a
larger degree than that of the mChoRE-b mutant counterpart in
HeLa cells (data not shown; also see Figure 1). Thus, in general,
ChoRE-a may have higher efficacies than ChoRE-b in sensing
extracellular glucose or adenosine-containing molecules.
Previously, we have shown that knock-down of MondoA or
MLX expression by small interfering RNAs (siRNAs) in U2OS
cells reduced the basal activity of the Txnip promoter and
abolished the induction by adenosine-containing molecules; for a
promoter with mutation at ChoRE-a, the effect of MondoA or
MLX siRNAs was diminished [37]. In this study, we found that
the activities of promoters with mutations at either ChoRE or both
ChoREs were largely unaffected by siRNAs targeting MondoA or
MLX (Figure 5). Thus, both the ChoRE motifs are required for
induction of Txnip promoter by adenosine-containing molecules,
which act most likely in a MondoA/MLX dependent manner.
ChoREs Are Not Sufficient for the Induction of Txnip
Expression
Both ChoREs are required for maximally inducing the Txnip
expression by adenosine-containing molecules or glucose
(Figure 4), and the promoter sequences spanning from 2184 to
263 appear to contain all the information necessary to mediate
the induction (Figure 2); however, we did not exclude potential
contribution(s) of other sequences lying between the two ChoREs,
thus asking whether the two motifs are sufficient for this
stimulatory process. We hence shuffled nucleotide sequences
between the two ChoREs (Shuffle, Figure 6A); the basal activity of
this mutant promoter was dramatically decreased, and the
promoter no longer responded to NAD
+ (Figure 6B) or glucose
(Figure 6C). We engineered tandem ChoRE-a or ChoRE-b
Figure 3. EMSAs using two Txnip promoter segments containing ChoRE-a or ChoRE-b. (A) the formation of DNA-protein complexes were
competed with different cold probes. (B) the effect of different antibodies on the migration of DNA-protein complexes. Refer to text for details. N.S.,
non-specific.
doi:10.1371/journal.pone.0008397.g003
Figure 4. Responses of wild-type (WT) or ChoRE mutant Txnip
promoters to NAD
+ or glucose. (A and B) the effect of NAD
+,i n
U2OS cells. (C and D) the effect of glucose, in L6 cells. Asterisk:
significantly induced by NAD
+ (A) or glucose (C); significantly different
from wild-type promoter (B and D).
doi:10.1371/journal.pone.0008397.g004
Txnip Gene Transcription
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reporter construct (Figure S5A); the activities of these chimerical
promoters were not induced by NAD
+ or Glucose (Figure S5B and
S5C). Hence, the two ChoREs are not sufficient for optimal
induction of the Txnip expression by adenosine-containing
molecules or glucose, and additional regulatory elements are
required.
Tandem NF-Y Binding Sites Are Required for the
Induction of Txnip Expression
The nucleotide sequences between two ChoREs contain a
CCAAT box, an inverted CCAAT box and a FOXO binding site
(Figure 2C); these three sites are highly conserved in Txnip
promoters from different species (Figure S2). In EMSAs, bands
corresponding to the CCAAT box or inverted CCAAT box were
super-shifted by NF-YA antibodies (Figure 3B), suggesting that
both the CCAAT and the inverted CCAAT boxes are potential
binding sites for NF-Y.
It was previously shown that mutated FOXO binding site did
not have significant effect on basal or NAD
+-induced Txnip
promoter activity, and that mutation at the inverted CCAAT box
led to decreased basal activity but the responsiveness to NAD
+ was
largely intact ([37]; also confirmed in Figure 7A and 7B). In this
study, the CCAAT box was also mutated (refer to Figure 2C), and
the mutant promoter behaved similarly as the inverted CCAAT
box mutant but to a larger degree; the promoter with mutations at
both CCAAT boxes was found to have a diminished basal activity
as well as an impeded induction by NAD
+ (Figure 7A and 7B). We
also examined effects of glucose on these promoters; promoters
with single mutations showed retarded glucose response, and the
double mutant promoter exhibited marginal response (Figure 7C
and 7D). In the promoter construct with shuffled nucleotides
between two ChoREs (Figure 6A), we inserted CCAAT boxes at
same positions as wild type Txnip promoter (Sh-CAT, Figure
S5A), and found that the activity of this promoter was induced by
glucose (not NAD
+) for ,2-fold and fully responsive to 2-deoxy-
glucose (2DG; Figure S5B and S5C), which is a glucose analog
that can massively mobilize MondoA and induce Txnip expression
[16]. Hence, NF-Y binding sites are not only important for
maintaining the basal level transcription, but also required for the
induction of Txnip expression by glucose; however, we do not rule
out the possibility that additional factors other than NF-Y and
MondoA/MLX, and their binding sites, might also be present for
mediating an optimal response of Txnip promoter to glucose and/
or adenosine-containing molecules.
Txnip Promoter Recruits MondoA/MLX Complex in an
NF-Y Dependent Manner
Results from promoter assays suggest that both NF-Y and
MondoA/MLX complex are required for a maximal induction of
Figure 5. The effect of siRNAs against MLX or MondoA on
Txnip promoter activity. siRNAs against MLX or MondoA down-
regulated the wild-type but not the ChoRE mutant Txnip promoters and
abolished the stimulatory effect of NAD
+ on Txnip promoters in U2OS
cells. Expression levels of MondoA or MLX were knocked down by
specific siRNAs as shown earlier [37]. R: random (control) siRNA. Asterisk:
comparison between NAD
+ treated and untreated samples; diamond:
comparison between basal activities (without NAD
+); n=2.
doi:10.1371/journal.pone.0008397.g005
Figure 6. Two ChoREs are not sufficient for mediating
stimulatory effect of NAD
+ or glucose. (A) a representation of
Wild-type (WT) Txnip promoter or Txnip promoter with scrambled
nucleotide sequences between two ChoREs (Shuflle) used in (B) and (C).
(B) the effect of NAD
+ on Txnip promoters in U2OS cells. (C) the effect of
glucose on Txnip promoters in L6 cells. Asterisk: comparison between
untreated samples and samples treated with NAD
+ or glucose;
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To confirm this, we performed chromatin immuno-precipitation
(ChIP) assays to determine the occupancy of NF-Y and MLX on
wild-type or mutant Txnip promoters that were parts of integrated
trans-genes in stable cell lines (see ‘‘Materials and Methods’’ and
Figure 8A for details). MLX was recruited normally to the wild
type promoter, efficiently recruited to the ChoRE-b mutant
promoter, and recruited to the ChoRE-a mutant promoter (albeit
with a reduced efficacy); when both ChoREs were mutated, the
MLX recruitment was completely impeded (Figure 8B). These
results suggest that both ChoREs are able to recruit the MondoA/
MLX complex, with the proximal ChoRE (ChoRE-a) being a
predominant binding site. This might be in line with the severities
of the mutations in the promoter functional analyses, especially
regarding the glucose response (Figure 4).
In ChIP assays, the wild-type Txnip promoter was precipitated
by both NF-YA and NF-YB antibodies; Txnip promoters with
single mutation at the CCAAT box or the inverted CCAAT box
were also precipitated by NF-Y antibodies although the signals
were reduced; however, the Txnip promoter with mutations at
both CCAAT boxes was not pulled-down by NF-Y antibodies
(Figure 8C). This confirms that both CCAAT boxes on Txnip
promoter are targets of NF-Y, and both sites are required for
optimal recruitment of NF-Y onto Txnip promoter.
NF-YA and NF-YB were recruited onto the double ChoRE
mutant (dmChoRE) promoters with a similar efficacy as the wild-
type promoter (Figure 9A). Thus the interaction of NF-Y with
CCAAT boxes is not dependent on ChoREs and their associated
factors. Interestingly, the interaction of MLX with the double
CCAAT boxes mutated promoter (dmCAT) was dramatically
reduced (Figure 9A). As controls, the occupancy of MLX or NF-Y
on endogenous Txnip promoters was similar in these cell lines; and
MLX and NF-Y did not interact with DNA sequences located
on a chromosome separated from the endogenous Txnip gene
(Figure S6).
The above experiments were performed using cells maintained
in complete DMEM with 1 g/L glucose; we also tested the Txnip
promoter occupancies by MLX or NF-Y in cells incubated in
glucose-free medium supplemented without or with glucose
(10 mM). As shown (Figure 9B and 9C), NF-YA was recruited
to the integrated (i) wild type or ChoRE-mutated (dmChoRE)
promoters or the endogenous (e) Txnip promoter at similar
efficacies under both the glucose-free and glucose-treated
conditions, but not to the double CCAAT box-mutated (dmCAT)
Txnip promoter, suggesting that the CCAAT box binding by NF-
Y was not sensitive to glucose. On the other hand, under glucose-
free condition, only residue amount of MLX was bound with the
Txnip promoters (WT or dmCAT) and, in cells treated with
glucose, the MLX recruitment to the integrated wild type and
endogenous Txnip promoters was dramatically increased; howev-
er, the MLX recruitment to the dmCAT promoter was
significantly repressed. The occupancies of the integrated wild
type promoter by MLX or NF-Y were similar to that of the
Figure 7. Responses of wild-type (WT) or CCAAT box mutant
Txnip promoters to NAD
+ or glucose. (A and B) the effect of NAD
+,
in U2OS cells. (C and D) the effect of glucose, in L6 cells. Asterisk:
significantly induced by NAD
+ (A) or glucose (C); significantly different
from wild-type promoter (B and D); diamond: basal promoter activities
were significantly different from WT promoter; n=2.
doi:10.1371/journal.pone.0008397.g007
Figure 8. ChIP assays. (A) Txnip promoters (wild-type or mutant)
were inserted into pEGFP-1 vectors using Xho I and BamH I sites, and
these constructs were used to generate G418-resistant stable cell lines,
which were used for ChIP assays. While primers a and b amplify the
chromosomally-integrated foreign Txnip promoters, primers c and d
amplify the endogenous Txnip promoter. (B) both ChoREs were able to
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chromosomally-integrated transfected promoter can function
similarly as the endogenous counterpart. Thus, mutations at the
CCAAT boxes can effectively disrupt the interaction of cognate
factors with the Txnip promoter, and the recruitment of NF-Y to
Txnip promoter is probably a prerequisite for the recruitment of
MondoA/MLX complex.
We also performed ChIP assays using different cells treated with
or without glucose or NAD
+. In HeLa cells, the occupancies of
MLX, MondoA and RNA polymerase II (Pol II) on Txnip
promoter were significantly increased under NAD
+ or glucose
treatment (Figure 10A and 10B). Histone proteins around Txnip
promoter was highly acetylated, even in cells incubated in glucose-
free medium for 16 hrs (Figure 10B), which suggests that the
Txnip gene promoter is relatively open at a non-induced state. We
also found that the interaction of ChREBP (a MondoA homolog,
also known as MondoB) with Txnip promoter was not detected in
HeLa cells (Figure 10B). Similar results were obtained when
U2OS or L6 cells were used (Figure S7A and S7B). On the other
hand, in INS-1 (pancreatic) or HepG2 (hepatic) cells, ChREBP,
rather than MondoA, occupies the Txnip promoter in a glucose-
inducible manner (Figure S7C and S7D). This is in line with high
ChREBP expression levels in these cell types and suggests that
either ChREBP or MondoA, in a tissue-selective way, may
function with MLX to support glucose induced Txnip expression.
Consistent with a potent response to NAD
+ [37], recruitment of
MLX, MondoA and Pol II to the Txnip promoter was increased
under NAD
+ treatment in U2OS cells (Figure S7E). In all tested
cell lines, the recruitment of NF-YA to the Txnip promoter was
largely constant, suggesting a role of NF-Y complex in maintaining
the basal transcription level of the Txnip gene.
Discussion
Tandem ChoREs on the Txnip Gene Promoter
It has been shown that the induction of Txnip expression by
glucose or adenosine-containing molecules was mediated by the
proximal ChoRE and its associated transcription factors Mon-
doA/MLX [16,22,37]. When testing responses of a series of
truncated or mutated Txnip promoters to NAD
+ or glucose
(Figures 1 and S1), we found that the sequence around 170 bp
upstream of the transcription start site was also critical for the
induction; this sequence is highly conserved in the Txnip
promoters of diverse species and resembles a degenerate ChoRE
(Figures 2, S2-S4). In EMSA and reporter assays, this newly
identified ChoRE, designated ChoRE-b, functioned similarly as
the previously reported ChoRE (ChoRE-a; Figures 3 and 4). In
ChIP assays, when ChoRE-a was mutated, MLX could be
recruited onto the Txnip promoter presumably via a weak
interaction with ChoRE-b (Figure 8B). Thus, we conclude that
there are two ChoREs on the Txnip promoter, in which the
ChoRE-b is also a significant contributor to the induction of Txnip
expression by glucose or adenosine-containing molecules in a
MondoA/MLX dependent fashion.
A recent study by other colleagues paid attention to the Txnip
promoter region around ChoRE-b as well, and concluded that a
potential ChoRE (GAGCACACCGTGTCCACGCG) was not
critical for the stimulatory effect of glucose on Txnip expression
[39]. Our view is that the ChoRE-b nucleotide sequences should
be GAGCACACCGTGTCCACGCG, especially when the fish
Txnip promoters were considered (Figure S4). Therefore, the
results and the conclusion in their study might be due to site-
directed mutagenesis that was off-target, or due to employment of
cells that were less sensitive to a missing function of ChoRE-b and
the associated factors. In our hands, the response of Txnip
promoters lacking a functional ChoRE-b to glucose treatment was
significantly reduced, which was observed in various tested cell
lines such as L6 (Figure 1B), HepG2, HeLa and C2C12 cells (data
not shown).
We realized, however, that the activities of ectopic Txnip
promoters lacking a functional ChoRE-b were induced by NAD
+
in HeLa cells but not in U2OS cells (Figure 1A); this may suggest
that the epigenetic statuses of the Txnip promoter may vary in
different cell types. The action of adenosine-containing molecules
is on top of the glucose-induced Txnip expression i.e., amplifica-
tion of the glucose signaling [37]; based on the integrity of glucose
signaling, the Txnip promoter in U2OS cells may have a more
open chromatin structure than that in HeLa cells. This may
explain the more dramatic induction of the Txnip expression in
U2OS cells than that in HeLa and other cells in responding to
NAD
+ or ATP [37]. In this scenario, the Txnip promoter in
U2OS cells could be more sensitive to missing functions of a
ChoRE-b element and associated MondoA/MLX. Alternatively,
and supported by preliminary results (data not shown), signaling
pathway(s) evoked by the adenosine-containing molecules in
U2OS cells could be unique and be different from those evoked
in HeLa or other cell types. Nevertheless, the glucose response, or
the response to adenosine-containing molecules, of the Txnip
promoter is a ubiquitous phenomenon.
Figure 9. ChIP assays. (A) the occupancy of MondoA/MLX on Txnip
promoter is contingent on the occupancy of NF-Y; cells were incubated
in complete DMEM with 1 g/L of glucose. (B) the occupancies of MLX or
NF-YA on Txnip promoters (i: integrated WT, dmChoRE or dmCAT Txnip
promoter; e: endogenous Txnip promoter) in cells maintained in
glucose-free medium supplemented without or with Glcuose (10 mM,
1 hrs). (C) quantification (using Real-Time PCR) for (B).
doi:10.1371/journal.pone.0008397.g009
Txnip Gene Transcription
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Within the minimal promoter (184–63) that supported full
induction (Figure 2B), two ChoREs, two CCAAT boxes and one
FOXO-binding site have been identified (Figure 2C). Among these
motifs, the FOXO-binding site is probably required for mediating
the inhibition of Txnip expression by insulin [20,25,40]; the
proximal ChoRE (ChoRE-a) has been shown to be critical for the
induction of Txnip expression by glucose or adenosine-containing
molecules [22,37]; and the inverted CCAAT box was identified as
an element responsible for mediating the stimulatory effect of
SAHA [13].
Here, however, we have found that both the distal (ChoRE-b)
and the proximal (ChoRE-a) ChoREs on Txnip promoter are
required for the induction of Txnip expression by glucose or
adenosine-containing molecules. It is possible that, for optimal
induction of Txnip expression, the two ChoREs might well be
organized in proximity by the interplay of their associated
transcription factors (MLX/MondoA) and cognate co-activators
to stimulate Txnip expression (Figure 10C). This is similar to a
model proposed for transcription stimulation of the MCP-1 gene,
in which two tandem nuclear factor kB (NF-kB) binding sites
recruit NF-kB proteins and co-activators p300/CBP upon TNF or
LPS stimulation [41].
Two tandem ChoREs alone, however, are not sufficient, and
two tandem NF-Y-binding sites, i.e., the CCAAT and the inverted
CCAAT motifs, are additionally required for optimal Txnip
expression induction by NAD
+ or glucose (Figures 6 and 7). Txnip
promoters with a singly mutated CCAAT box exhibited much
reduced activities but nevertheless retained the induction poten-
tials by NAD
+ or glucose; however, when both CCAAT motifs
were mutated, the induction potentials were completely abolished
(Figure 7). We propose that the NF-Y-binding sites are not only
critical for maintaining a basal Txnip promoter activity but also
involved in the induction of Txnip expression by glucose or
adenosine-containing molecules, presumably through sustaining
certain chromatin status that helps optimize the induction
(Figure 10C; and also see below).
NF-Y and MondoA/MLX Cooperate to Stimulate Txnip
Expression
The NF-Y is a complex containing NF-YA, NF-YB and NF-YC
subunits, all of which are required for interaction with the
CCAAT motif that is a widely distributed promoter element in
human genome [42]. NF-Y can recruit certain histone acetyl-
transferases (HATs) such as GCN5 and p300/CBP-associated
factor (PCAF) onto a target promoter, adding acetylation marks
onto histones and transcription factors [43]. These epigenetic
marks usually positively impact target gene transcription (reviewed
in [44]). Consistent with this notion, the inverted CCAAT box is
known to mediate the Txnip expression induction by SAHA [13],
which as a histone deacetylase inhibitor can in principle counter-
act the removal of the above epigenetic marks hence sustaining
gene activation.
Our ChIP results indicate that NF-Y was recruited onto the
Txnip promoter via both CCAAT boxes (Figure 8C); this
promoter occupation seems to be a prerequisite for the
recruitment of the MondoA/MLX complex (Figure 9). Hence,
NF-Y and MondoA/MLX might coordinate to maximize the
Txnip expression. NF-Y constitutively occupies the Txnip
promoter even in glucose-free medium, and this binding might
facilitate the Txnip promoter occupancy, in a glucose-dependent
manner, by MondoA/MLX. These promoter-bound factors in
turn recruit co-activator(s), which set up local epigenetic
environment that favors the induction by other signals from,
e.g., adenosine-containing molecules (Figure 10C).
A very recent paper has reported the Txnip promoter dynamics
under glucose treatment in INS-1 cells, of pancreatic origin, using
Figure 10. ChIP asssys and a working model. The occupancy of MLX, MondoA, ChREBP, Pol II or NF-YA on the Txnip promoter in HeLa cells
under NAD
+ (0.1 mM for 4 hrs; A) or Glucose (10 mM for 1 hr; B) treatment; the acetylation status of Txnip promoter associated H3 and H4 under
different conditions was also examined. Asterisk: significantly induced by NAD
+ or glucose. (C) a model for the transcriptional regulation of the Txnip
gene promoter by NF-Y, MLX, Mondo (MondoA or ChREBP) and other (co)factors. See text for further details.
doi:10.1371/journal.pone.0008397.g010
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ChREBP can recruit p300 to increase histone acetylation, which
in turn enhances recruitment of Pol II to induce the Txnip
transcription. Indeed, we found that ChREBP, but not MondoA,
was recruited to the Txnip promoter in (pancreatic) INS-1 cells
and (hepatic) HepG2 cells (Figure S7C and S7D). In our hands,
these cell lines express high ChREBP levels, as opposed to low
levels of MondoA (not shown). Thus, in a cell-context-dependent
manner, either MondoA or ChREBP may respond to glucose
evoked signaling and induce Txnip expression (Figure 10C; here,
Mondo represents either MondoA or ChREBP); however, we do
not rule out the possibility that transmitting the glucose signaling
to MondoA or ChREBP (in complex with MLX) might involve
distinct intermediate molecules.
It has been shown that NF-Y can also cooperate with several
other transcription factors, such as upstream stimulatory factors
(USF1/2), Oct1, GATA-1, SP-1, ATF-2, Regulatory factor X
(RFX) and sterol regulatory element binding protein-1 (SREBP1)
[46–52] to regulate the transcription of target genes under
nutritional, hormonal or immunological challenges. For instance,
the promoter of another metabolic related gene, that of the type II
Hexokinase (HKII), contains a CCAAT box, an inverted CCAAT
box and multiple GC boxes that are bound by the SP family
transcription factors [53]. CCAAT box-containing promoters
might employ a common regulatory mechanism in which NF-Y
might function as a regulator that facilitates the function of other
gene specific transcription factors to induce gene transcription as
illustrated in Figure 10C. On the more distal Txnip promoter
region, there is a vitamin D response element and a glucocorticoid
response element [13,30]; it would be of high interest to study if
NF-Y can also cooperate with vitamin D or glucocorticoid




Cells were maintained under 5% CO2 at 37uC in low glucose
(1 g/L) DMEM supplemented with antibiotics, L-glutamine and
10% fetal bovine serum (HyClone, Logan, UT). The glucose-free
DMEM medium was supplemented with (additional) 2 mM of
sodium pyruvate. DMEM was from Sigma Chemical Co. (St.
Louis, MO), and other supplements were from Invitrogen
(Carlsbad, CA).
RNA Extraction, RT (Reverse Transcription)-PCR, and Real-
Time PCR
RNA was extracted using RNeasy Mini Kit (QIAGEN,
Valencia, CA). Reverse transcription was carried out using
SuperScript III reverse transcriptase and random hexamers,
RNaseOUT was used to maximize RNA stability (all reagents
for reverse transcription were from Invitrogen). PCR and Real-
Time PCR were carried out using the Taq DNA polymerase (New
England Biolabs, Ipswich, MA) and Sybr Green Core Reagents
(Applied Biosystems, Foster City, CA) respectively. Same primers
(synthesized by Proligo, Singapore) were used in RT-PCR and
Real-Time PCR, the sequences of primers are shown in Table S1.
Plasmid Constructs
Phusion DNA polymerase (Finnzymes, Espoo, Finland) was
used in constructing Txnip promoter plasmids with deletions or
mutations. From a long Txnip promoter, various promoter
fragments were generated by subsequent PCR, covering 1299,
269, 169, 163, 142, 102 and 73 bp Txnip promoter sequences (to
the transcription start site), and inserted into the pGL3 vector
using the Xho1 and Nhe1 sites. Mutations at ChoREs or CCAAT
boxes were introduced into the wild-type Txnip prompter (2269)
by PCR. MondoA and MLX expression constructs were described
in Yu et al. [37].
siRNAs
The sequence information of siRNAs against MondoA or MLX
was described in Yu et al. [37].
Transfection
Cells cultured in 6-well plates (about 80% confluency) were
washed with OPTI-MEM (Invitrogen) and used for transfection.
During transfection, a mixture of 4 ml of lipofactamine 2000
(Invitrogen), 1 mg of Txnip promoter plasmid and 10 ng of simian
virus 40 (SV40)-renilla luciferase plasmid (top up to 100 ml using
OPTI-MEM) were prepared. After 20 min, the mixture was
added drop-wise into the well with cells incubated in OPTI-MEM
(0.9 ml). At 5 hrs, the medium was replaced with complete
medium. For co-transfection of plasmids and siRNA, 5 mlo f
lipofactamine 2000, 1 mg of Txnip promoter plasmid, 100 pmole
siRNA and 10 ng of renilla luciferase plasmid were used.
Promoter Activity (Reporter) Assays
Cells were treated with 0.2 mM of NAD(H) or 10 mM of
glucose for 16 hrs after transfection. Cell lysates were prepared
and the firefly or renilla luciferase activities were measured using
the Dual-Luciferase Reporter Assay System (Promega, Madison,
WI).
Electrophoresis Mobility Shift Assay (EMSA)
Oligonucleotides (synthesized by Proligo, see Table S2 for
sequences information) were labeled with [a-
33P]dATP (GE
Healthcare, Bucks, UK) using Klenow enzymes (exo
2, New
England Biolabs). In a typical binding reaction, 10 fmole end-
labeled oligonucleotides in 26 EMSA buffer (25 mM Hepes-
KOH at pH 7.9, 62.5 mM KCl, 0.05% Nonidet P-40, 2 mM
MgCl2, 8% Ficoll 400, 500 mg/ml BSA, and protease inhibitors)
were mixed with 5 mg of whole cell extract prepared from HeLa
cells over-expressing HA-MondoA and Myc-MLX; the reaction
was carried out at room temperature for 30 min. For competition
assays, 1006molar excess cold oligonucleotides were added; and
for antibody inhibition or super-shift assays, 0.5 mg of each
antibody was included in the binding reaction. Protein-DNA
complexes were then separated on 4% polyacrylamide gels (in
6.25 mM Tris at pH 8.2, 50 mM Glycine, 0.1 mM EDTA, 1 mM
MgCl2, 0.025% Nonidet P-40 and 0.5 mM DTT) and visualized
by autoradiography.
Chromatin Immunoprecipitation (ChIP)
Wild-type or mutant Txnip promoter (same as promoters used
in luciferase reporter assay) was inserted into pEGFP-1 vector.
These plasmid constructs and empty pEGFP-1 vector were
transfected into HeLa cells. G418 resistant colonies were selected,
and stable cell lines were established and used for ChIP assays.
The presence of these plasmids in stable cells lines were confirmed
by PCR or fluorescence microscopy. Following different treat-
ments, cells were treated with 1% formaldehyde for 10 min at
room temperature, and DNA-protein cross-linking reaction was
stopped by the addition of glycine. Cells were harvested and
washed with PBS twice and then incubated in cold MC buffer [54]
for 30 min. Cells were then subjected to sonication and
immunoprecipitation using ChIP assay kit (Millipore, Bedford,
Txnip Gene Transcription
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ratio) was used for pre-clearance and pull-down of antibody-
protein-DNA complexes, and DNA fragments extricated from
these complexes were purified using QIAquick PCR Purification
Kit (Qiagen). Finally, recovered DNA fragments of interest were
analyzed by PCR using Taq DNA polymerase (New England
Biolabs). Antibodies used in ChIP assays are: MLX (AF4186;
R&D Systems, Minneapolis, MN), NF-YB (pAb-077-050; Diag-
enode, Belgium), AcH4 and AcH3 (06-598 and 06-599, Millipore),
Pol II (MMS-126R; Covance, Princeton, NJ), all other antibodies
(NF-YA, sc-100779; ChREBP, sc-21189; MondoA, sc-133397;
and navie IgGs) are from Santa Cruz Biotechnology (Santa Cruz,
CA). The information of PCR primers used is shown in Table S1.
Statistical Analyses
Unpaired t-test was used for data analysis in this study, and two
tailed P value less than 0.05 was considered statistically significant.
P values less than 0.05 was indicated by asterisk (*) or diamond (¤),
and P values less than 0.005 was indicated by double asterisks or
diamonds; data without these indicators suggest P values at $0.05.
Supporting Information
Figure S1 Promoter activity of Txnip promoters. (A) In HeLa
cells, promoters with a 142 bp or longer Txnip promoter sequence
were induced by NAD
+. (B) In U2OS cells, promoters with a
169 bp or longer Txnip promoter sequence were induced by
NAD
+. (C) In L6 cells, promoters with a 142 bp or longer Txnip
promoter sequence were induced by glucose. Asterisks indicate the
promoter was significantly induced by NAD
+ or glucose (refer to
‘‘experimental procedures’’ for details of statistics).
Found at: doi:10.1371/journal.pone.0008397.s001 (0.39 MB JPG)
Figure S2 Alignment of Txnip promoters from different species.
Sequence alignment of Txnip promoters. Txnip promoter
sequences of different species were aligned using CLUSTAL W
program. The conserved cis-elements (ChoREs, FOXO-binding
site, CCAAT, or inverted CCAAT) were highlighted using boxes.
Found at: doi:10.1371/journal.pone.0008397.s002 (0.97 MB TIF)
Figure S3 The phylogenetic tree built from Txnip promoters of
different species using the Neighbor-Joining (NJ) method.
Found at: doi:10.1371/journal.pone.0008397.s003 (0.33 MB JPG)
Figure S4 Sequence alignment of fish and frog Txnip promoters
with human Txnip promoter. Sequences corresponding to
ChoRE-a in fish Txnip promoters are not a good ChoRE (as
indicated by red boxes). Sequences corresponding to ChoRE-b in
fish Txnip promoters are more similar to the canonical ChoRE
(green box with dotted lines).
Found at: doi:10.1371/journal.pone.0008397.s004 (0.45 MB JPG)
Figure S5 The response of hybrid Txnip promoters to NAD
+ or
glucose. (A) Fusion of a TATA box-driven luciferase reporter with
Txnip prompters. Shuffle, nucleotide sequences between two
ChoREs were scrambled; Sh-CAT, shuffle with two CCAAT
boxes; other promoters contain two ChoREs. (B) The activity of
the wild-type Txnip promoter, but not the other Txnip promoters,
was induced by NAD
+. (C) The activity of Txnip promoters
without CCAAT boxes was not induced by glucose. Note that the
Sh-CAT promoter showed normal basal activity (not shown),
which was not significantly induced by NAD
+ (B), but was
significantly and fully induced, respectively, by glucose and 2DG
(C).
Found at: doi:10.1371/journal.pone.0008397.s005 (0.51 MB JPG)
Figure S6 ChIP assays. (A) The endogenous Txnip promoter
was precipitated in a similar fashion using different cell lines. (B) A
negative control DNA was not precipitated by antibodies against
MLX or NF-YB.
Found at: doi:10.1371/journal.pone.0008397.s006 (0.21 MB JPG)
Figure S7 ChIP assays. The interaction of MLX, MondoA,
ChREBP, Pol II, or NF-YA with Txnip promoter was analyzed in
different cells under glucose (A–D) or NAD
+ (E) treatment. The
acetylation status of Txnip promoter-associated H4 was also
examined.
Found at: doi:10.1371/journal.pone.0008397.s007 (0.72 MB JPG)
Table S1 Sequence information of oligonucleotides.
Found at: doi:10.1371/journal.pone.0008397.s008 (0.05 MB
DOC)
Table S2 Sequence information of probes used in EMSA.
Found at: doi:10.1371/journal.pone.0008397.s009 (0.04 MB
DOC)
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